Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

HER-2 Protein Vaccine in Treating Women With Breast Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Case Comprehensive Cancer Center Identifier:
First received: September 10, 2003
Last updated: February 4, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)